Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.30 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | SLC12A2 | P55011 | 1/20 | 0.30 |
| ▸ | SLC12A5 | Q9H2X9 | 1/20 | 0.30 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6705581 | 0.86 | GLA (0.39) | GLAMAPTL3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL6705574 | 0.80 | MAPT (0.38) | GLAMAPTL3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL5863647 | 0.73 | RAPGEF4 (0.39) | RORCKEAP1NFE2L2 | |
| SCHEMBL5864026 | 0.71 | KEAP1 (0.39) | CYP2C9CYP2C19RORCKEAP1NFE2L2 | |
| SCHEMBL5863634 | 0.70 | NR1H2 (0.38) | RORCKEAP1NFE2L2 | |
| SCHEMBL6705577 | 0.70 | SLC40A1 (0.33) | GLAMAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL5863809 | 0.66 | CYP2D6 (0.48) | GLAMAPTL3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL5864051 | 0.66 | ABL1 (0.40) | — | |
| SCHEMBL5864216 | 0.64 | SIGMAR1 (0.40) | TDP1MEN1KMT2AKEAP1NFE2L2 | |
| SCHEMBL5864868 | 0.64 | SIGMAR1 (0.38) | CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110767-A1 | Acyclic amide and sulfonamide ligands for the estrogen receptor | PFIZER INC | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110767-A1 | Acyclic amide and sulfonamide ligands for the estrogen receptor | GHSR, GPER1, SSTR1 | GLA 183/4885MAPT 4755/4885L3MBTL1 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.